Key Therapeutic Areas
Dosage Forms & Representations
Solid Dosage
320 mil/annum-
Tablets
-
Capsules
-
Sachets
Liquid/Aerosol
20 mil/annum-
Spray
-
Inhalers
-
Liquid
General Area
Semi Solid
4.0 mil/annum-
Eye Gel
-
Eye Ointment
Liquid Dosage
110 mil/annum-
UDV
-
Ampules
-
Vials
-
SVP/LVP
-
Eye Drops
-
Suspension
-
Lyophilized Powder
Sterile Area
Biologics
-
Formulation & FF
-
Therapeutic Proteins
-
Biosimilars
-
Vaccines
-
mAbs
-
Cell & GeneTherapy
-
mRNAs
-
ADCs
Bio Area
CDMO
- Technology Transfer
- Capacity for Clinical and Commercial Manufacturing
- End-to-End Service, DS, DP, and FF
- Fully Flexible, Single Use Facility
In/Out Licensing
- Coming Soon
- Coming Soon
Co-Development
- Coming Soon
- Coming Soon